Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Other Comprehensive Income (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Net sales (Note 3) $ 3,040 $ 1,402 $ 5,716 $ 3,439
Cost of sales (Note 3) 2,608 1,205 5,060 2,929
Gross profit 432 197 656 510
Operating expenses (Note 3):        
Sales and marketing 150 153 486 686
Administration 1,124 734 3,510 2,881
Research and development 60 43 318 202
Total operating expenses 1,334 930 4,314 3,769
Other income (expense), net 125 (53) 222 (158)
Loss from continuing operations before income taxes (Note 7) (777) (786) (3,436) (3,417)
Income tax benefit from continuing operations 305 1,322
Loss from continuing operations (472) (786) (2,114) (3,417)
Discontinued operations (Note 4):        
Income from discontinued operations 953 530 1,121
Gain (loss) on sale of discontinued operations, net of taxes (305) 42,389
Income (loss) from discontinued operations (305) 953 42,919 1,121
Net income (loss) (777) 167 40,805 (2,296)
Other comprehensive loss:        
Unrealized loss on marketable securities (Note 3): (35) (35)
Total comprehensive income (loss) $ (812) $ 167 $ 40,770 $ (2,296)
Basic earnings (loss) per share:        
Loss from continuing operations $ (0.03) $ (0.05) $ (0.13) $ (0.20)
Income (loss) from discontinued operations (0.02) 0.06 2.58 0.07
Net income (0.05) 0.01 2.45 (0.13)
Diluted earnings (loss) per share:        
Loss from continuing operations (0.03) (0.04) (0.13) (0.20)
Income (loss) from discontinued operations (0.02) 0.05 2.51 0.07
Net income (loss) $ (0.05) $ 0.01 $ 2.38 $ (0.13)
Weighted average common shares outstanding:        
Basic 15,967,000 17,081,000 16,661,000 17,081,000
Diluted 15,967,000 17,600,000 17,118,000 17,081,000